MedPath

Endomimetics™ Awarded $2.8 Million Phase II SBIR Grant to - GlobeNewswire

Endomimetics awarded $2.8M SBIR grant to research Bionanomatrix™ coating for flow diverters in treating brain aneurysms, aiming to accelerate endothelialization and reduce thromboembolic risks.


Reference News

Endomimetics™ Awarded $2.8 Million Phase II SBIR Grant to Develop and Evaluate the ...

Endomimetics awarded $2.8M SBIR grant to research Bionanomatrix™ coating on flow diverters for brain aneurysm treatment, aiming to accelerate healing and reduce complications.

Endomimetics™ Awarded $2.8 Million Phase II SBIR Grant to - GlobeNewswire

Endomimetics awarded $2.8M SBIR grant to research Bionanomatrix™ coating for flow diverters in treating brain aneurysms, aiming to accelerate endothelialization and reduce thromboembolic risks.

© Copyright 2025. All Rights Reserved by MedPath